Diagnostic Imaging Systems Market Demand to Assist in Product Developments
The X-ray imaging systems category dominated the global market and
generated revenue worth $15.2 billion in 2018, which is projected to reach
$20.5 billion by 2024, progressing at a CAGR of 5.2% during the forecast period
(2019–2024). Besides, the industry witnessed fastest growth in the category of
nuclear imaging systems. The growth of this category is mainly driven by
increasing prevalence of cancer, and rising demand for these systems across the
globe. Furthermore, the market size for ultrasound systems, which stood at $5.9
billion in 2018, is expected to reach $8.3 billion by 2024, witnessing a CAGR
of 6.0% during the forecast period.
The governments across the globe are running awareness programs to
educate people regarding early diagnosis of chronic diseases, especially breast
cancer, lung cancer, cardiovascular diseases, diabetes, arthritis, and
tuberculosis. Such initiatives are leading to increase in awareness regarding
early diagnosis of diseases among healthcare providers and patients. Diagnostic
imaging has helped doctors to diagnose diseases earlier, thereby improving
patient outcomes. Diagnostic imaging systems improve healthcare quality and
reduce healthcare cost by shortening recovery time and avoiding unnecessary
invasive procedures. Such factors are playing pivotal role in the growth of
diagnostic imaging systems market.
Download
PDF Sample Copy of Research Report:
Mexico is a growing marketplace for diagnostic
imaging systems in the LATAM and is expected to generate around $1.5
billion by 2024. This can be attributed to the surging geriatric population,
and increasing prevalence of chronic diseases in the country as compared to
other countries in the region.
Due to technological advancements and rapid urbanization, Saudi Arabia
is expected to hold larger share, of 32.2%, by 2024, in the MEA market.
However, due to large patient population and increasing government initiatives
to make healthcare accessible to every citizen, the industry is expected to
witness faster growth in South Africa, registering a CAGR of 6.3% during the
forecast period.
In January 2019, the U.S. Food and Drug Administration (USFDA)
approved Siemens Healthineers’s MAGNETOM Lumina 3 Tesla MRI scanner. The system
features BioMatrix patient personalization technology, which significantly
improves productivity while reducing scan time. Furthermore, in September 2018,
Carestream Health Inc. received the USFDA 510(k) Clearance for its OnSight 3D
Extremity System. This imaging system uses cone beam CT technology to capture
weight-bearing and other types of extremity exams.
Other prominent players in the diagnostic imaging
systems market include Konica Minolta Inc., Dornier MedTech
GmbH, SternMed GmbH, MinFound Medical Systems Co. Ltd., DRGEM CO. LTD.,
SonoScape Medical Corporation, Analogic Corporation, and Fonar Corporation.
Comments
Post a Comment